Suicide genes: monitoring cells in patients with a safety switch
Clinical trials increasingly incorporate suicide genes either as direct lytic agents for tumors or as safety switches in therapies based on genetically modified cells. Suicide genes can also be used as non-invasive reporters to monitor the biological consequences of administering genetically modifie...
Main Authors: | Linda Groppe Eissenberg, Michael eRettig, Farrokh eDehdashti, David ePiwnica-Worms, John F. DiPersio |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00241/full |
Similar Items
-
An Adenovirus Vector Containing the Suicide Gene Thymidine Kinase for a Broad Application in Cancer Gene Therapy
by: GS Magalhães, et al.
Published: (2002-06-01) -
Case report: Stem cell-based suicide gene therapy mediated by the herpes simplex virus thymidine kinase gene reduces tumor progression in multifocal glioblastoma
by: Saeed Oraee-Yazdani, et al.
Published: (2023-03-01) -
Editorial: Improving the safety of cell therapy products by suicide gene transfer
by: Elodie eBole-Richard, et al.
Published: (2015-08-01) -
Alpha-Herpesvirus Thymidine Kinase Genes Mediate Viral Virulence and Are Potential Therapeutic Targets
by: Ying Xie, et al.
Published: (2019-05-01) -
Imaging Transgene Expression with Radionuclide Imaging Technologies
by: S.S. Gambhir, et al.
Published: (2000-01-01)